Last updated: 2026-10-12 22:00:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
908 Devices Inc. (MASS) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $11.83, with a market capitalisation of $498.07M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.03 to $13.35. This page covers its latest market performance, valuation, price trends and company information.
$498.07M | |
$12.22 | |
$79.60 | |
$1.81 | |
$12.05 | |
184.44K | |
415.79K | |
-- | |
$13.35 | |
$5.03 | |
-- | |
-- |
908 Devices Inc. (MASS) is trading at $11.83 in after-hours trading as of 2026-10-12 19:59:41, down 1.87% ($0.23) from the regular-session close of $12.05.
After-hours trading shows how investors are pricing MASS after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, 908 Devices Inc. (MASS) moved from $12.51 to $11.83, representing a decline of 5.45% ($0.68).
The stock traded between $11.14 and $13.35 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 441.68 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 81.7%
MASS is currently trading at $11.83, placing it 81.7% of the way from its 52-week low of $5.03 to its 52-week high of $13.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 172 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of 908 Devices Inc. (MASS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.